Promise Of US Tax Reform Simmers, But On The Backburner

The pharmaceutical industry will have to keep waiting for US tax reform, most likely until at least the end of 2017. President Trump plans to revisit health care reform first to generate the savings needed for "phenomenal" tax reform.

Money Wave

US corporate tax reform is arguably the single policy change pharmaceutical manufacturers most want President Trump and the Republican-led Congress to get done, but now it appears a tax overhaul will be delayed until after Congress takes another swing at health care reform.

"We're going to have a phenomenal tax reform, but I have to do health care first," Trump said in an...

More from Business

More from Scrip